This collection will give you access to select recordings of the 2017 Annual Meeting presentations and some of the associated pdf slides (see the topics tab for a complete list of the talks) .

Continuing education credit is no longer available.

The AMP 2017 Annual Meeting (November 16-18, 2017 in Salt Lake City, UT) showcased an impressive roster of speakers covering a wide range of topics in molecular diagnostics. The theme for the meeting was "Where Molecular Leads Medicine to Best Patient Care" and the presentations highlighted the true clinical utility of molecular diagnostics. In AMP 2017 Annual Meeting Highlights, catch up on the the most cutting-edge research in molecular pathology in topics ranging from CRISPR technologies, liquid biopsies, and the microbiome, to epigenetic roles in human disease, and new tools for interpreting the cancer genome. Click on the "Topics" tab for a list of the available presentations and click on the titles for more information about each session.

Duration:  13.25 hrs

If you have questions, please email AMPeducation@amp.org

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

AMP is the leading organization in the field of molecular diagnostics, and the AMP Annual meeting is the premier gathering of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on the AMP meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.

This collection contains downloadable PDF slides of many of the presentations given during the AMP 2017 Annual Meeting. See the "topics" tab for a list of all the presentations for which slides are available.

The digital files (PDFs) for the AMP 2017 Annual Meeting are:

• Free for all AMP members until February 15, 2018. After February 15, 2018 (11:59PM EST), the price increases to $99.00.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2018.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. Click here for instructions on how to access the presentation slides.

Join the AMP Family for a discount on this item.

Please note that this webinar was recorded in 2016. All AMPED^TM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

This collection will give you access to the recordings of the presentations (listed below) and pdf slides only. CME/CMLE or SAM is not available for this collection

Description:

Did you miss out on joining us in Charlotte for the AMP 2016 Annual Meeting? Were you there but missed something you really wanted to see? We have you covered with the AMP 2016 Annual Meeting Highlights. Select presentations were recorded and are now available for online viewing.

CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential

The concept of a pre-cancer� clonal proliferation is fundamental to our understanding of the natural evolution of a variety of cancer types and an active area of research. Recent recognition of pre-malignant clonal hematopoiesis has been yet another exciting discovery in this area. The speakers will discuss their work in identifying Clonal Hematopoiesis of Indeterminate Potential (CHIP) and its relationship to both aging and the subsequent development of recognized hematopoietic malignancies.

- Explain the concept of clonal hematopoiesis.

- Describe how clonal hematopoiesis can be evaluated using markers identified by high-through sequencing.

- Summarize current knowledge regarding the association between clonal hematopoiesis and the development of recognized hematopoietic cancers, particularly myelodysplastic syndromes.

Clonal Hematopoiesis of Indeterminate Potential

Benjamin Ebert, MD, PhD, Brigham and Women's Hospital

CHIP, ICUS, MDS: A Clinical Perspective

David P. Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, USA

Duration: 1.5 hr

Recording Date: November 10, 2016

You might also be interested in:

• AMP 2018 Annual Meeting Recordings
• AMP 2017 Annual Meeting Highlights
• More on AMPED^TM

Note: Join the AMP Family to purchase this content for a deep discount!

The AMP 2016 Annual Meeting (November 10-12, 2016, Charlotte, North Carolina) showcased research in the latest advances in molecular medicine with the goal of enabling the highest quality health care.

The purchase of this product provides you with downloadable PDF slides of many of the AMP 2016 Annual Meeting presentations. See the "topics" tab for a list of all the presentations with slides available.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This collection will give you access to select recordings from the AMP 2017 Global Congress. If you would like continuing education credit for the webinar, see the table below to purchase the collection + CME/CMLE or collection + SAM.

The AMP 2017 Global Congress in Berlin was a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. AMP Education has assembled the “AMP 2017 Global Congress Highlights,” which includes a selection of some of the most highly rated presentations and asked the speakers to record their talks from the meeting. This selection of excellent presentations includes:

Duration: 3.75 hr

Level of Instruction: Basic

You can purchase individual talks or purchase all of the AMP 2017 Global Congress Highlights for a discount.

• To purchase the entire series, click the "Add to Cart" button located on the right.
• To purchase individual talks, click on the "Purchase Individual Topics" button on the right, and select the particular talk(s) that you would like to purchase.

If you would like continuing education credit, click on the links below.

If you have questions, please email AMPeducation@amp.org

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

The AMP 2017 Global Congress (April 3-5, 2017 in Berlin, Germany) highlighted a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. The emphasis was on modern, user-friendly laboratory analytics supported by informatics tools to facilitate interpretation of actionable genomic test results.

The purchase of this product provides you with downloadable PDF slides of many of the presentations given during the AMP 2017 Global Congress. See the "topics" tab for a list of all the presentations with slides available.

The digital files (PDFs) for the AMP Global Congress 2017 Meeting are available free to meeting registrants for a limited time (three months) after the conference.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical, except that AMP authorizes you to view, copy, download and print for your own purposes.

AMP is the leading organization in the field of molecular diagnostics, and the AMP Annual meeting is the premier gathering of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on the AMP meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.

This collection contains downloadable PDF slides of many of the presentations given during the AMP 2018 Annual Meeting and Expo. See the "topics" tab for a list of all the presentations for which slides are available.

The digital files (PDFs) for the AMP 2018 Annual Meeting are:

• Free for all AMP members until February 15, 2019. After February 15, 2019 (11:59PM EST), the price increases to $99.00.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2019.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. Click here for instructions on how to access the presentation slides.

Join the AMP Family for a discount on this item.

This collection will give you access to the sessions recorded at the 2018 Annual Meeting presentations and the associated pdf slides (see the topics tab for a complete list of available talks).

If you would like continuing education credit, see the table below to purchase the collection + CME/CMLE or the collection + SAM.

AMP is the leading organization in the field of molecular diagnostics, and the AMP Annual meeting is the premier gathering of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on the AMP meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.

Many of the sessions from the AMP Annual Meeting and Expo were recorded and this collection contains all the recorded sessions and downloadable PDF slides. See the "topics" tab for a list of all the presentations for which recordings and slides are available.

Duration: 49.25 hrs total

If you have questions, please email AMPeducation@amp.org

If you wish to obtain CME/CMLE or SAMs, click on the appropriate link to purchase the collection +CME/CMLE or +SAM.

* You may not submit SAMs and CME/CMLE credit for the same content.

Note: Join the AMP Family to purchase this content for a deep discount!

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to access the recordings

1. Click here for instructions on how to access the presentation slides.

Join the AMP Family for a discount on this item.

AMP hosted the Reference Materials forum to discuss genetic testing reference materials availability and needs (for test validation, quality control, and proficiency testing). Speakers presented a variety of current reference material development projects for molecular testing of inherited and acquired somatic genetic disorders followed by group discussion. 

This collection contains downloadable PDF slides of many of the presentations given during the Reference Material Forum Meeting which took place on October 30, 2018 in San Antonio, Texas. Click here for more details about the meeting.

The digital files (PDFs) for the Reference Material Forum Meeting are:

• Free for all AMP members.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2019.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. To access the presentation slides, click on "My classroom" on the menu to the right.
6. Click on "AMP 2018 Reference Material Forum Meeting Presentations and Handouts.
7. Under "Resources", click on the PDF buttons to download the materials.

All sales are final. No refunds will be issued.

Join the AMP Family for a discount on this item.

This collection contains downloadable PDF slides of many of the presentations given during the AMP Europe 2018 Congress (April 30 - May 2, 2018).  Click here for more information about the meeting.

The digital files (PDFs) from AMP Europe 2018 are:

• Free for all AMP members until August 31, 2018. After August 31, 2018 (12:00 PM EST), the price increases to $99.00.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until August 31, 2018.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Purchase and Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. Click here for instructions on how to access the presentation slides.

You may also be interested in:

• AMP Europe 2018: Presentation Recordings (contains the recorded talks and slides)

Join the AMP Family for a discount on this item.

This collection will give you access to recordings to many of the presentations from AMP Europe 2018 and its associated pdf slides (see the topics tab for a complete list of the talks). There is no CME or SAM credit included in this collection.

AMP Europe 2018 in Rotterdam, Netherlands (April 30 - May 2, 2018) showcased the current advances, challenges, and solutions for the advancement of precision cancer medicine. If you missed the meeting or would like to re-watch some of the presentations, this collection is for you. See the "topics" tab for a list of all the available recorded presentations. Click here for more information about the meeting.

Duration:  approximately 9 hrs

If you have questions, please email AMPeducation@amp.org

You may also be interested in:

• AMP Europe 2018: Handouts (only PDFs of presentations)
• AMP 2017 Annual Meeting Highlight (Select Recordings of AMP Annual Meeting 2017)
• More on AMPED^TM

Join the AMP Family for a discount on this item.

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This collection contains downloadable PDF slides of many of the presentations given during the AMP Global 2019 (May 16 - May 18, 2019).  Click here for more information about the meeting.

The digital files (PDFs) from AMP Global 2019 are:

• Free for all AMP members until August 31, 2019. After August 31, 2019 (12:00 PM EST), the price increases to $99.00.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until August 31, 2019.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Purchase and Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. Click here for instructions on how to access the presentation slides.

You may also be interested in:

• AMP 2018 Annual Meeting Presentations and Handouts
• AMP 2018 Annual Meeting Recordings (CE Available)
• AMP Europe 2018: Handouts
• AMP Europe 2018: Presentation Recordings

Join the AMP Family for a discount on this item.

This AMP certificate program contains 5 hours of lecture content, the lecture slides, a key reference sheet, a post-course exam, and an AMP Certificate of Completion. It does not include CME/CMLE or SAM. If you would like to obtain CE credit for this program, see the table below to purchase CME/CMLE or SAM.

Description:

Since the publication of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues in 2008, there have been significant advances in our knowledge of the biology and genetics of hematopoietic malignancies resulting in improved diagnostic and prognostic criteria, disease classification and therapeutic strategies. The 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues incorporates these advances with revisions to current entities and addition of provisional entities. This AMP certificate program will cover the major changes made in the 2016 WHO revision. Participants will learn from experts in the field covering the following topics: B lymphoid neoplasms, Peripheral T cell lymphomas, Acute Leukemias, Myeloproliferative Neoplasms, Myelodysplastic syndromes and Myelodysplastic/myeloproliferative neoplasms. An update on the clinicopathologic features and classification of hematologic malignancies will be presented providing participants with skills and knowledge to accurately diagnose and subclassify hematologic malignances according to the revised 2016 WHO criteria.

Target Audience: Practicing pathologists, oncologists, medical trainees and other healthcare professionals in the U.S. and abroad.

This certificate program was planned and coordinated by the Content Directors:

• Jennifer Dunlap, MD, Oregon Health & Science University, Portland, OR
• Mark D, Ewalt, MD, University of Colorado, Denver, CO

and supported by the Training & Education Committee (Cecilia C.S. Yeung, MD, Chair) 

Duration: 5 hours

Certificate Program Topics (for details about each topic, click on the “Topics” tab at the top of the page)

• B-Lymphoid Neoplasms (Eric D. Hsi, MD)
• Nodal Peripheral T-cell Lymphomas (Stefano A. Pileri, MD)
• Acute Leukemias (Daniel A. Arber, MD)
• Myeloidproliferative Neoplasms (Tracy I. George, MD)
• MDS and MDS/MPN (Robert Hasserjian, MD)

The content for this certificate program was made in collaboration with Association for Molecular Pathology (AMP) and Society for Hematopathology (SH)

CME/CMLE or SAMs: If you wish to obtain CME/CMLE or SAMs, click on the appropriate link to purchase the collection +CME/CMLE or +SAM. These also contain the AMP Certificate of Completion

* You may not submit SAMs and CME/CMLE credit for the same content.

You might also be interested in:

• AMP 2017 Annual Meeting Highlights: Molecular Genetics and Biomarkers of B-cell Leukemias and Lymphomas
• AMP 2016 Annual Meeting Highlights: CHIPping Away at the Mysteries of Hematopoiesis
• More on AMPEDTM

Note: Members of AMP can access this at a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This course is designed for pathologists, residents, laboratory directors and technologists who have some prior exposure to molecular diagnostic testing. The course features introductory information about the state of the science as well as a series of case studies illustrating some of the most current principles and practices in the field of Molecular Pathology. Attendees from all career levels will benefit from this staple offering.

The objective of this course is to increase basic and applied pathology knowledge, focusing on the molecular diagnosis of disease and to facilitate knowledge acquisition regarding issues and challenges related to care and prevention. This course is designed to meet the participants' educational needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care.

Contemporary hot topics in the clinical molecular diagnostics laboratory will be introduced, followed by an overview of genomic testing to build the molecular diagnostic "toolkit." Short case presentations will demonstrate practical applications of a wide range of methodologies ranging from common commercial platforms to traditional amplification methods.

Duration: 5.25 hours

CME or SAMs is no longer available for this course

This online course includes all the recorded presentations, course materials, and case studies from the live 2018 Molecular Pathology Outreach Course held on October 31, 2018 in San Antonio, TX.

CME/CMLE and SAMs credit are available with the purchase of this course.

This course is designed to provide an overview of techniques and instrumentation used from the framework of the "Molecular Pathology/Molecular Diagnostic Toolkit." In this course, faculty members will present case studies to demonstrate the toolkit’s methodologies and technologies. Emphasis will be placed on molecular testing in the areas of clinical genetics, solid tumors, hematopathology, and infectious diseases. The application of novel technologies, such as next generation sequencing and informatics, will also be highlighted.

Visit the Program page for more information.

Audience: Pathologists, residents, laboratory directors and technologists who have little experience with molecular diagnostic testing.

Duration: 3.5 hrs

Maximum CME/CMLE credit available: 3.0 

Maximum SAM credit available: 3.0 

Last day to purchase course and claim credit: October 31, 2019

Note - registrants who attended the face-to-face course do not need to register for the online course to access the online materials.

CME/CMLE and SAM Credit:

How to claim credit: To earn credit, all learners must watch the lectures, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz and the online survey, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

CME/CMLE Credit

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology (AMP). The ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this online educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the ASCP for up to 3.0 hours of CMLE credit. ASCP CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

SAM Credit

This activity is approved by the American Board of Pathology for a maximum of 3.0 SAM Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly).

SAM edited by: Yi Ding, MD, PhD; Honey Reddi, PhD; Midhat Farooqi, PhD

* You may not submit SAMs and CME/CMLE credit for the same content.

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This online course includes all the recorded presentations, course materials, case studies, and tests from the live course held on May 16-19, 2019. CME/CMLE or SAMs is available with the purchase of this course until December 31, 2020.

This course features an intense update and review of molecular diagnostics for those prepping for the Molecular Genetic Pathology (MGP) Subspecialty Certification Exam as well as other certification exams, those who need a refresher, or anyone looking to add molecular testing to their current pathology practice. Participants have the opportunity to learn directly from recognized experts in the field of molecular pathology. Learn at your own pace and rewatch lectures as many times as you'd like.

Go here for more information on the course. 

Duration: 

The course will be available to purchase until December 31, 2020 (11:59PM Eastern), but please note that the course will also expire in your classroom on December 31, 2020. If you need access beyond December 31, please email AMPEducation@amp.org and we will consider a limited extension on a case-by-case basis. 

Note - registrants who attended the face-to-face course do not need to register for the online course to access the online materials.

CME/CMLE credit and SAMs credit are both available with the purchase of this course.

* You may not submit SAMs and CME/CMLE credit for the same content.

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 20.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensuratesam with the extent of their participation in the activity. 

SAM Credit: The AMP 2019 MGP Review Course is approved by the American Board of Pathology for up to 19.50 SAM credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. Learners must pass the post-test with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.  If you are seeking continuing education credit for an accrediting board other than the ABP, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).

Note: Members of AMP can access this course for a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Welcome to the Fellowship-in-Service-Examination 2019 brought to you by the Molecular Genetic Pathology (MGP) Program Directors and the Association for Molecular Pathology.

These exam questions were written by MGP faculty from many MGP-Fellowship institutions and cover the range of topics listed below. For each examination, a total of 45 questions populated from a question bank of nearly 250 questions will be randomly generated. At the end of the examination, you will receive your results along with the correct responses, an explanation of the correct choice, and references for further information. You will only receive this information for each question answered, so you are encouraged to answer all questions, regardless of whether or not you know the correct answer.

You are welcome to take the exam as many times as you like, but please note that participants will be charged a small administrative fee ($25 for AMP members, $50 for non-members) each time they take the exam.

Good luck!

MGP Category Codes (in alphabetical order):

1. Constitutional disorders

2. Hematopathology

3. Identity Testing and Histocompatability

4. Infectious disease

5. Informatics and Genomics

6. Laboratory Management, Regulatory, Ethical and Legal topics

7. Laboratory Test development and validation

8. Molecular Genetic Pathology principles and methods

9. Pharmacogenetics

10. Professionalism and Professional Development

11. Solid tumor, including inherited cancer syndromes

Professionalism Statement:

The Molecular Genetic Pathology Fellowship In-Service Exam was developed by the MGP Program Directors Council, the AMP Training and Education Committee and faculty from several Molecular Genetic Pathology Fellowship training programs as a tool to assess program performance and to identify areas of strength as well as those needing improvement. We hope that you find the Molecular Genetic Pathology Fellowship In-Service Exam to be a useful tool and rely on the participants to exemplify professionalism by not copying or sharing content, so that this resource continues to be a low-cost and useful tool to evaluate and improve MGP fellows training. 

DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The Molecular Genetic Pathology Question Bank is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).

How to Purchase:

1. Under the "Products" menu on the right, click the "add to basket" button.
2. Login with your AMP Member/Customer Username and Password. 
3. Proceed to "Checkout".
4. Provide your payment information by clicking “Edit my Billing Info”.
5. Save your billing information and click “Submit Order”.
6. You will receive a confirmation email from Peach New Media.

All sales are final. No refunds will be issued.

Note: Join the AMP Family to purchase this content for a discount!

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This presentation summarizes the findings of the Association for Molecular Pathology Chronic Myeloid Neoplasm Working Group. Chronic myeloid neoplasms (CMNs) are defined as a complex group of hematopoietic disorders, encompassing myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), the overlap entities (MDS/MPNs), and systemic mastocytosis. The goal of this group was to distill the vast amounts of literature on the mutational profiles of the CMNs into high impact information that would aid molecular pathologists in the development of next generation sequencing (NGS) myeloid panels. This work identifies 34 genes as the minimum recommended testing list and provides information on the frequency of these genes in the various CMNs as well as their prognostic and therapeutic import. In addition, the findings highlight the recurrent patterns of mutational clonal evolution in these patients, uncovering critical insight into the biology of these neoplasms.

Practice Guideline Available Here

Speaker: Annette S. Kim, MD, PhD

Moderator: Todd W. Kelley, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies (+AMP Certificate)
• CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential
• WHO 2016 Updates: Myeloproliferative Neoplasms
• More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Please note that this webinar was recorded in 2016. All AMPED^TM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

Description:

In this webinar, Dr. Zehir talks about the structural variation in the genome and the ways it relates to disease formation and treatment. He focuses on the different strategies to detect and visualize them using next-generation sequencing technologies for the clinical laboratory with a focus in cancer. 

Speaker: Ahmet Zehir, PhD

Host: N. Sertac Kip, MD, PhD

Duration: 40 min.

Level of Instruction: Advanced

You might also be interested in:

• Dealing with Highly Homologous Genes in the Context of Medical Sequencing
• Standards and Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists
• NGS 101: Introduction to the Fundamentals of Next-Generation Sequencing
• More on AMPED^TM

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This webinar will review the most recent revision of the World Health Organization (WHO) classification of acute leukemia with a particular focus on acute myeloid leukemia. A summary of changes to the classification of lymphoblastic leukemia/lymphoma and acute leukemias of ambiguous lineage will also be summarized.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Daniel A. Arber, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Certificate Program (the entire series + AMP Certificate)
• Other WHO Updates in this series (webinar only):
  • WHO 2016: Updates: B-Lymphoid Neoplasms (and how practice is changing)
  • WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
  • WHO 2016 Updates: MPN
  • WHO 2016 Updates: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
  • More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

In this presentation, Dr. Hsi will review important changes in the recently published update to the 2016 WHO classification of B-cell neoplasms. Topics include monoclonal B-cell lymphocytosis, in situ follicular neoplasia, pediatric type follicular lymphoma, and provisional entities such as large B-cell lymphoma with IRF rearrangement and EBV+ mucocutaneous ulcer. The appropriate molecular characterization of diffuse large B-cell lymphomas and high grade B-cell lymphomas will also be discussed.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Eric D. Hsi, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You might also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Certificate Program (the entire series + AMP Certificate)
• Other WHO Updates in this series (webinar only):
  • WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
  • WHO 2016 Updates: Acute Leukemias
  • WHO 2016 Updates: MPN
  • WHO 2016 Updates: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
• AMP 2017 Annual Meeting Highlights: Molecular Genetics and Biomarkers of B-cell Leukemias and Lymphomas
• AMP 2016 Annual Meeting Highlights: CHIPping Away at the Mysteries of Hematopoiesis
• More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

In this webinar, Dr. Tracy George will discuss updates in the classification of myeloproliferative neoplasms, also including eosinophilic neoplasms with recurring mutations, and mastocytosis. This includes new criteria for accelerated phase (response-to-TKI criteria) in chronic myeloid leukemia, WHO 2016 criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis, as well as eosinophilic neoplasms with and without recurring mutations. Updates in the diagnosis of mastocytosis, now its own chapter again in the WHO 2016 classification, will also be explained.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Tracy I. George, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You might also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Certificate Program (the entire series + AMP Certificate)
• Other WHO Updates in this series (webinar only):
  • WHO 2016: Updates: B-Lymphoid Neoplasms (and how practice is changing)
  • WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
  • WHO 2016 Updates: Acute Leukemias
  • WHO 2016 Updates: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
  • More on AMPEDTM

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

Following a brief overview on the difficulties encountered in the definition of the epidemiology, classification, diagnosis, prognosis, and therapy of peripheral T/NK-cell lymphomas, nodal peripheral T-cell lymphomas (PTCLs) will be discussed in detail. These neoplasms account for more than 60% of tumours stemming from peripheral T-lymphocytes. In the Revised WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, they correspond to 4 entities: PTCL, not otherwise specified (NOS), PTCLs related to follicular helper T-lymphocytes (FTH), ALK+ anaplastic large cell lymphoma (ALCL), and ALK- ALCL. Tumour related to TFH cells represent a new category, including angioimmunoblastic T-cell lymphoma (AITL), follicular T-cell lymphoma and neoplasms lacking the morphologic characteristics of the previous two subtypes but also stemming from TFH-elements. The latter group was in the past included among PTCLs/NOS. ALK- ALCL was promoted from provisional to accepted entity because of emerging molecular evidences. In addition, the new provisional category of breast implant-associated ALCL was included. Most of the changes introduced in the Revised WHO Classification by comparison with the 2008 fourth edition are due to the extensive application of molecular techniques, including gene expression profiling and next generation sequencing. All the changes will be highlighted and discussed.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Stefano A. Pileri, MD

Host: Jennifer Dunlap, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Certificate Program (the entire series + AMP Certificate)
• Other WHO Updates in this series (webinar only):
  • WHO 2016: Updates: B-Lymphoid Neoplasms (and how practice is changing)
  • WHO 2016 Updates: Acute Leukemias
  • WHO 2016 Updates: MPN
  • WHO 2016 Updates: Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
  • More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This webinar reviews the updated diagnostic criteria of myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms according to the recently revised WHO Classification, with emphasis on significant changes from the prior (2008) WHO Classification. New and revised entities within this group of diseases will be presented and the appropriate testing required to correctly diagnose these neoplasms will be discussed.

Speaker: Robert P. Hasserjian, MD

Host: Jennifer Dunlap, MD

Duration: 1 hr

Level of Instruction: Basic

If you would like continuing education credit, click on the links below.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies Certificate Program (the entire series + AMP Certificate)
• Other WHO Updates in this series (webinars only)
  • WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing)
  • WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
  • WHO 2016 Updates: Acute Leukemias
  • WHO 2016 Updates: MPN
  • More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

In January 2017, a working group comprised of representatives from the Association for Molecular Pathology (AMP), College of American Pathologists (CAP), American Society of Clinical Oncology (ASCO), and American College of Medical Genetics and Genomics (ACMG) published the guidelines for the interpretation and reporting of somatic variants. This subject matter expert panel comprised of investigators with expertise in molecular pathology, medical genetics, and clinical oncology, assessed the current status of NGS-based testing for cancer and established standardized classification, annotation, interpretation, and reporting conventions for sequence variants associated with cancer.

In this webinar, Dr. Marilyn M. Li summarizes the guideline and provides a number of examples illustrating how to implement the classification system.

Practice Guideline Available Here

Speaker: Marilyn M. Li, MD

Host: Antonia R. Sepulveda, MD, PhD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines
• More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This presentation summarizes the findings of the Association for Molecular Pathology Chronic Myeloid Neoplasm Working Group. Chronic myeloid neoplasms (CMNs) are defined as a complex group of hematopoietic disorders, encompassing myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), the overlap entities (MDS/MPNs), and systemic mastocytosis. The goal of this group was to distill the vast amounts of literature on the mutational profiles of the CMNs into high impact information that would aid molecular pathologists in the development of next generation sequencing (NGS) myeloid panels. This work identifies 34 genes as the minimum recommended testing list and provides information on the frequency of these genes in the various CMNs as well as their prognostic and therapeutic import. In addition, the findings highlight the recurrent patterns of mutational clonal evolution in these patients, uncovering critical insight into the biology of these neoplasms.

Practice Guideline Available Here

Speaker: Annette S. Kim, MD, PhD

Moderator: Todd W. Kelley, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• 2016 World Health Organization (WHO) Updates in Hematologic Malignancies (+AMP Certificate)
• CHIPping Away at the Mysteries of Hematopoiesis: The Science and Clinical Implications of Clonal Hematopoiesis of Indeterminate Potential
• WHO 2016 Updates: Myeloproliferative Neoplasms
• More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

   This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Speaker: Lawrence J. Jennings, MD, PhD	Moderator:  Antonia R. Sepulveda, MD, PhD

Description: Validation of NGS-based testing for oncology panels can be challenging given the many steps and wide range of targeted mutations. In this presentation, Dr. Jennings will discuss the recent AMP/CAP guideline recommendations for validation and review practical ways to provide documented evidence with the clinical NGS reports.

Practice Guideline Available Here

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

* You may not submit SAMs and CME/CMLE credit for the same content.

You may also be interested in:

• Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines
• AMP/ASCO/CAP Standards and Guidelines of Somatic Variant Interpretation and Reporting
• More on AMPEDTM

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Please note that this webinar was recorded in 2016. All AMPED^TM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

Recent definitions for clinical utility of molecular tests focus on whether a test result will alter treatment. This definition neglects other uses of molecular testing to diagnose disease, manage symptoms, prognosticate or predict future disease. The fullest realization of precision medicine will require embracing all aspects of clinical utility. This three-part webinar series, supported by AMP, presents the discussions of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility (FEND) working group, and its resulting publication, “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology” (Joseph L, et al. J Mol Diagn. 2016;18[5]:605–619).

Part 1 - An Overview of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility

Speakers: Loren Joseph, MD; Elaine Lyon, PhD

Host: Roger Klein, MD, JD

Part 2 - AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Oncology Cases

Speakers: Pranil Chandra, DO, FCAP, FASP; Rajyasree Emmadi, MD, FCAP

Host: Loren Joseph, MD

Part 3: AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Inherited Conditions

Speakers: Stephanie Hallam, PhD, FACMG, MBA; Victoria Pratt, PhD, FACMG

Host: Elaine Lyon, PhD

Practice Guideline Available Here

Total Duration: 3 hr

Level of Instruction: Advanced

You might also be interested in:

• Other AMP Practice Guidelines
• More on AMPED^TM

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!